Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrossword Cybersecurity Regulatory News (CCS)

  • This share is currently suspended. It was suspended at a price of 1.75
  • There is currently no data for CCS

AGM Result. Board Changes. Share sub-division. TVR

25 May 2021 15:26

RNS Number : 6471Z
Crossword Cybersecurity PLC
25 May 2021
 

Crossword Cybersecurity Plc

Result of AGM

Board Changes

Total Voting Rights

 

25 May 2021 - London, UK - Crossword Cybersecurity Plc (AIM:CCS, "Crossword", the "Company" or the "Group"), the technology commercialisation company focused on cyber security and risk management, announces that, at its AGM held today, all resolutions put to the meeting were duly passed.

 

Share sub-division

As a result of one of the resolutions passed by Shareholders, each existing Ordinary Share of 5p is being sub-divided into 10 new ordinary shares of 0.5p each ("New Ordinary Shares"). The ISIN for the New Ordinary Shares will be GB00BNG2LT65.

Application has been made for the admission of 57,618,900 New Ordinary Shares to trading on AIM ("Admission") with Admission expected to occur on 26 May 2021. CREST accounts are expected to be credited on the same day and the date of dispatch of definitive share certificates in respect of the New Ordinary Shares is expected on or around 10 June 2021.

 

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), following Admission, Crossword will have 57,618,900 New Ordinary Shares in issue with voting rights attached. Crossword holds no shares in treasury. This figure of 57,618,900 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the DTRs.

 

Board Changes

Crossword is also pleased to announce the appointment of Tara Cemlyn-Jones and Robert Coles to the board of the Company as non-executive directors with immediate effect.

Tara Cemlyn-Jones has 28 years' experience in financial services with specialist knowledge of capital markets, M&A, strategy and digital transformation across many sectors, including financial services (asset & wealth management, retail banking and fintech), energy & infrastructure and healthcare. Tara Cemlyn-Jones was head of M&A at Lastminute.com and has held senior positions at Schroders, Citigroup and Espirito Santo Investment Bank. She is the founder and currently director of 25 x 25 Ltd, a not for profit enterprise co-ordinating the initiative to get more women CEOs into UK Business.

Tara Persis Cemlyn-Jones, aged 50, is a director of 25 X 25 Limited.

There is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules. Tara Cemlyn-Jones does not own any shares in the Company.

 

Dr Robert Coles is a highly experienced IT Risk and Cyber Security leader. He is the former Chief Information Security Officer of GlaxoSmithKline (GSK) and of the NHS, with over 30 years commercial experience. Prior to his time at the NHS, Dr Robert Coles worked for GlaxoSmithKline (GSK) from 2013 and was the company's Chief Information Security Officer (CISO). Before GSK, Dr Coles served as CISO for the National Grid and Merrill Lynch. Dr Coles is an Honorary Professor at UCL and Governor of University of Brighton and a member of its Audit Committee and has extensive links with major industry information security networking groups and government security agencies. Dr Coles is Chair of Crossword's Advisory Board as well as of the Group's subsidiary, Crossword Consulting Limited.

Robert Stephen Coles, aged 54, is a director of Crossword Consulting Limited and Cumberland House Consulting Limited. There is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules. Robert Coles does not own any shares in the Company. 

 

As previously announced, Gordon Matthew and David Stupples have retired from the Board at the conclusion of the AGM. The other Directors would like to thank both Gordon Matthew and David Stupples for their service to the Company.

 

Tom Ilube CBE, CEO of Crossword Cybersecurity Plc, said: "I am pleased to report that Crossword has made a strong start to 2021. We are experiencing great success from strategies to increase Rizikon market penetration. In the last 6 months this has increased 10 fold, with the number of Rizikon users exceeding 250. I am delighted to welcome Dr Robert Roles and Tara Cemlyn-Jones who join the Board today. Robert is a very experienced Chief Information Security Officer and former KPMG Partner who has been involved with Crossword for a while, chairing both our consulting business and our Advisory Board. Tara has extensive investment banking and mergers and acquisitions experience both in the UK and across Europe and we will be leveraging her knowledge and contacts as we scale up."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

Contacts

Crossword Cybersecurity plc - Tel: +44 (0) 20 3953 8460

Email: info@crosswordcybersecurity.com

Tom Ilube, Chief Executive Officer

Mary Dowd, Chief Financial Officer

 

Grant Thornton (Nominated Adviser) - Tel: +44 (0) 20 7383 5100

Colin Aaronson / Lukas Girzadas

 

Hybridan LLP (Broker) - Tel: +44 (0)203 764 2341

Claire Louise Noyce

 

For media enquiries contact:

Duncan Gurney, GingerPR

duncan@gingerpr.co.uk - Tel: +44 (0)1932 485 300

 

About Crossword Cybersecurity plc

Crossword Cybersecurity plc focuses on the development and commercialisation of university research-based cyber security and risk management related software and cyber security consulting. The Group's specialist cyber security product development and software engineering teams work with its university partners to develop the research concept into a fully-fledged commercial product that it will then take to market. The Group's aim is to build up a portfolio of revenue generating, intellectual property based, cyber security products. Rizikon Assurance, Crossword's leading product, is a SaaS platform that enables medium to large companies to assess and manage all risks from their suppliers. Nixer CyberML, Crossword's most recently launched product, is a new tool for businesses that want to solve advanced security and cybercrime problems, such as detecting and dealing with compromised accounts, fraud, and in-application denial of service attacks. Crossword's team of expert cyber security consultants leverages years of experience in national security, defence and commercial cyber intelligence and operations to provide bespoke advice tailored to its clients' business needs.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEAKSLALNFEFA
Date   Source Headline
18th Nov 20247:00 amRNSCancellation - Crossword Cybersecurity plc
15th Oct 20244:45 pmRNSBusiness and assets sale update. Nomad resignation
11th Oct 20247:00 amRNSFinancial Update and Proposed Asset Sale
1st Oct 20247:30 amRNSSuspension - Crossword Cybersecurity plc
27th Sep 20244:45 pmRNSComment on Delay to Publication of Accounts
27th Sep 20242:48 pmRNSDelay to Interim Accounts. Suspension of Shares
20th Sep 202411:51 amRNSResult of General Meeting
4th Sep 20247:00 amRNSShareholder Circular and Notice of General Meeting
30th Aug 20247:00 amRNSAppointment of part-time Head of Finance
14th Aug 20247:00 amRNSCFO resignation and £1m pa cost reductions
31st Jul 20244:01 pmRNSHolding(s) in Company
31st Jul 20247:00 amRNSTotal Voting Rights
25th Jul 20247:00 amRNSHolding(s) in Company
18th Jul 20247:00 amRNSEquity fundraising incl. Director's subscription
18th Jun 20247:00 amRNSRizikon Partnership with Global Defence Company
23rd May 20243:11 pmRNSResult of AGM
21st May 20247:00 amRNSChair and CEO Transition Plans
16th Apr 20247:00 amRNSCFO Transition
12th Apr 20242:47 pmRNSHolding(s) in Company
11th Apr 20245:30 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSNew Head of Consulting
9th Apr 20247:00 amRNSSecurity in the Caribbean
3rd Apr 20247:00 amRNSBoard Appointment
28th Mar 20247:00 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSLaunches new CyberAI Practice
15th Mar 20242:15 pmRNSHolding(s) in Company
14th Mar 20245:46 pmRNSHolding(s) in Company
12th Mar 20247:00 amRNSIssue of Shares
5th Mar 20247:00 amRNSIssue of Loan Notes and Related Party Transactions
27th Feb 20247:00 amRNSLaunch of Trillion HarVitsa
15th Feb 20247:00 amRNSPartnership with TD Synnex
2nd Jan 20247:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSTrading Update
25th Oct 20231:56 pmRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSIssue of Loan Notes
28th Sep 20237:00 amRNSInterim Results & Notice of Investor Presentation
1st Sep 20233:37 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSH1 Trading Update & Issue of Loan Notes
27th Jul 202312:11 pmRNSResult of General Meeting
10th Jul 20237:00 amRNSShareholder Circular and Notice of AGM
6th Jun 20237:00 amRNSThreat Intelligence Monitoring Contract
30th May 20237:00 amRNSShare Option Awards
24th May 20231:24 pmRNSDirector/PDMR Shareholding
23rd May 202310:29 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSRelated Party Transaction
22nd May 202311:23 amRNSResult of AGM
16th May 20239:53 amRNSDirector/PDMR Shareholding
15th May 20232:59 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSTop 100 Cybersecurity firms
9th May 20234:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.